Login

Miguel Sieler, CEO, Neovacs 00:00:00

Share On Facebook Share On Twitter

CEO Miguel Sieler talks about his company's commitment to finding a cure for Lupus.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease|Joe Todisco,Chief Executive Officer,CorMedix Inc
00:10:00
Exploring Growth Opportunities: Argonaut Resources at the One-to-One Mining Investment Conference
00:10:00
In-Depth Discussion on Working Capital with Mark Kenney, CEO of CAPREIT|CEO,Canadian Apartment Properties Real Estate Investment Trust
00:10:00
COVID-19: Spending Priorities | Jenn Steliga - Advisor of Time Well Spent Financial Coaching LLC
00:10:00
Leading with Soul: Insights from André Lacroix, CEO of Intertek Group | André Lacroix - Chief Executive Officer of Intertek Group plc
00:10:00
Forte Minerals CEO Patrick Elliott Discusses Copper and Gold Focus in Peru
00:10:00
investing in different spaces such as software marketplaces and e commerce|Rafael Corrales,Founder,Background Capital
00:10:00
GPTs: A Wonderful Addition to the AI Ecosystem|Konstantine Buhler,Partner,Sequoia Capital
00:10:00
research-focused style of investing and regularly make early|Dharmesh Thakker,General Partner,Battery Ventures
00:10:00
Nicholas Yrizarry Explores Behavioral Finance Insights on ThisDay
00:10:00
An Emerging Global Leader in the New Generation of Anti-Infective Therapies|James Graham,Managing Director,Recce Ltd
00:10:00
They invest in founders, primarily in the southeast, working on early-stage tech companies|Shila Nieves Burney,General Partner,Zane Ventures

© 2026 Nehu